Bioanalytical Systems (BASI) Reports Q4 Loss of $0.09/Share

Bioanalytical Systems (NASDAQ: BASI) reported Q4 EPS of ($0.09), versus ($0.05) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.42 million reported last year.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• OceanaGold to acquire Ausgold in a deal valued at A$776M
• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform